Advertisement
Skip to Content

VanEck Pharmaceutical ETF PPH

Quantitative rating as of | See VanEck Investment Hub
  • NAV / 1-Day Return 77.46  /  0.09 %
  • Total Assets 459.6 Mil
  • Adj. Expense Ratio
    0.350%
  • Expense Ratio 0.360%
  • Distribution Fee Level
  • Share Class Type
  • Category Health
  • Investment Style Large Value
  • Min. Initial Investment
  • Status Open
  • TTM Yield 1.53%
  • Turnover 23%

Morningstar’s Analysis PPH

Will PPH outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Summary

|

VanEck Pharmaceutical ETF's Average People Pillar and Process Pillar ratings hold this strategy's Morningstar Quantitative Rating of Neutral. The portfolio maintains a cost advantage over competitors, priced within the lowest fee quintile among peers.

Unlock our full analysis with Morningstar Investor